News
Three essential educational guides
Boost Staff Knowledge, Confidence & Patient Safety Empower your dispensary team with our three essential educational guides, created to support day-to-day operations and improve patient care: Essential Dispensary Manager’s Guide...
Dispensary Profitability Review
Our consultant will typically spend about 2 hours in the dispensary, observing and asking questions. He will look at processes and potential efficiencies. Our consultant will then need to spend...
Class 2 Medicines Recall: ChloraPrep 1mL Clear Sterile Solution/Applicator, Becton Dickinson UK Ltd, EL(25)A/36
Source: MHRA/Gov.uk 28.7.25 Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This is linked to the Class...
Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension , CD Pharma Ltd, EL(25)A/35
Source: MHRA/Gov.uk 24.7.25 CD Pharma Ltd have notified the MHRA of an error on the outer carton of the product for the batches listed in this notification. While the total...
Trinity Biotech Premier Hb9210™ HbA1c Analyser: Risk of Positive Bias and Updates to Instructions for Use (IFU), including use as a diagnostic aid in diabetes mellitus (DSI/2025/003)
Source: MHRA/Gov.uk 22.7.25 The MHRA has received reports describing a positive bias in HbA1c results delivered by the Trinity Biotech Premier Hb9210 HbA1c analyser, which has resulted in patients being...
Stay Informed with the Dispex WhatsApp Support Group!
We’re pleased to see many of you joining and engaging with the community since our launch on March 1st. The group offers a supportive space where you can share best practices, ask...
Dispex Training Options
Dispex is considered to be the leading educational company in the UK, providing professional training, advice and consultancy which purely focuses on dispensing practices- as well as providing profitability tools...
CQC’s Annual Controlled drugs update report for 2024
Source: The CQC -15th July 2025 The safer management of controlled drugs 2024 report highlights our oversight activity under the Controlled Drugs (Supervision of Management and Use) Regulations 2013. It includes what...
SOPs Page Update
By Dispex After receiving constructive feedback, we have added a “Template last updated by Dispex ” column, allowing members to easily see whether they need to replace their current SOP with...
Is there a required ink colour for GP signatures on FP10s?
By Dispex Dr Philip Koopowitz: “There is no indication about restriction of the colour of ink. Indeed NHSBSA is not mandated to check that a signature is on the script...
Diabetes – Glucagon-like Peptide-1 receptor Agonists (GLP1)
By Dispex More and more patients are being started on GLP1 agonists in an attempt to bring their diabetes and weight under control. There are 7 injectable brands, as well...
DDA Annual Conference – Update
It is now less than 10 weeks until the DDA Annual Conference which takes place at the National Conference Centre (NCC), near the NEC, Birmingham on Wednesday 24th and Thursday...
